Zepbound prescribing information instructs users to inject under the skin in the abdomen (at least 2 inches from the belly button), front of the thigh, or back of the upper arm and to rotate sites with each dose
As research on GLP-1 receptor agonists like semaglutide grows, a clearer picture is forming
The relative abundances of Clostridium subcluster 4 of bacteria in the fecal samples were evaluated using quantitative PCR, which was performed using SYBR Green (Takara Bio, Kusatsu, Shiga, Japan) and an Mx3000P real-time PCR system (Agilent Technologies Japan Ltd., Tokyo, Japan), as reported previously [9]
As enthusiasm for these medications has grown, eating disorder specialists have begun paying attention to a different question: What happens when someone with a history of anorexia begins losing weight
So far, some studies in people using semaglutide for diabetes or weight loss have reported increased energy levels